These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 22008772)
21. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes? Jonsson G; Furin J Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840 [No Abstract] [Full Text] [Related]
22. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416 [TBL] [Abstract][Full Text] [Related]
23. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134 [TBL] [Abstract][Full Text] [Related]
24. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region]. Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972 [TBL] [Abstract][Full Text] [Related]
25. Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo. Shanks L; Masumbuko EW; Ngoy NM; Maneno M; Bartlett S; Thi SS; Shah T Int J Tuberc Lung Dis; 2012 Aug; 16(8):1066-8. PubMed ID: 22565108 [TBL] [Abstract][Full Text] [Related]
26. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran. Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919 [TBL] [Abstract][Full Text] [Related]
27. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases]. Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128 [TBL] [Abstract][Full Text] [Related]
28. Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic. Rodriguez M; Monedero I; Caminero JA; Encarnación M; Dominguez Y; Acosta I; Muñoz E; Camilo E; Martinez-Selmo S; de los Santos S; del Granado M; Casals M; Cayla J; Marcelino B Int J Tuberc Lung Dis; 2013 Apr; 17(4):520-5. PubMed ID: 23485386 [TBL] [Abstract][Full Text] [Related]
29. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of acquired MDR-TB and HIV co-infection. Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236 [TBL] [Abstract][Full Text] [Related]
31. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Kliiman K; Altraja A Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304 [TBL] [Abstract][Full Text] [Related]